Markets remain heavily focused on AI despite mounting pressure from the Iran conflict, rising energy costs and growing signs of strain across the global economy.
Good morning! Here’s everything you need to know before the ASX flings open its doors and begins trading today.
Artrya’s FDA-cleared AI heart imaging tools are now reimbursable in the US, targeting one of healthcare’s deadliest blind spots: hidden heart disease.
As rising rates squeeze parts of Australia’s lending sector, MoneyMe says its variable rate loan book is helping protect margins.
Ariana Resources is stepping up development at its Dokwe gold project in Zimbabwe to feed into a DFS due in Q1 2027.
